Publications by authors named "Rafael Llorens"

Claim this Profile
C
Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients' Sera.
Adrià Duran, Pedro E Guerrero, Maria Rosa Ortiz, Dúnia Pérez Del Campo, Ernesto Castro, Rafael de Llorens

Biomedicines· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nucleus-directed bombesin derivative for targeted delivery of metallodrugs to cancer cells.
Sílvia Barrabés, Iteng Ng-Choi, María Ángeles Martínez, Blanca R Manzano, Félix A Jalón, Rafael de Llorens

J Inorg Biochem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the main PSA glycoforms in aggressive prostate cancer.
Anna Gratacós-Mulleras, Adrià Duran, Akram Asadi Shehni, Montserrat Ferrer-Batallé, Manel Ramírez, Rafael de Llorens

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion.
Pedro Enrique Guerrero, Laura Miró, Bin S Wong, Anna Massaguer, Neus Martínez-Bosch, Rafael de Llorens

Int J Mol Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Esther Llop, Pedro E Guerrero, Adrià Duran, Sílvia Barrabés, Anna Massaguer, Rafael de Llorens

World J Gastroenterol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum.
Esther Llop, Montserrat Ferrer-Batallé, Sílvia Barrabés, Pedro Enrique Guerrero, Manel Ramírez, Rafael de Llorens

Theranostics· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs.
Ma Ángeles Martínez, M Pilar Carranza, Anna Massaguer, Lucia Santos, Juan A Organero, Rafael de Llorens

Inorg Chem· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Experience with the Latest-Generation Biological Prosthesis, the Trifecta™ GT.
Federico Paredes, Arnaldo Estigarribia Bernal, Eduard Permanyer, Javier Poncela, Alejandro Ysasi, Rafael Llorens

J Heart Valve Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.
Esther Llop, Montserrat Ferrer-Batallé, Sílvia Barrabés, Pedro Enrique Guerrero, Manel Ramírez, Rafael de Llorens

Theranostics· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.
Sílvia Barrabés, Esther Llop, Montserrat Ferrer-Batallé, Manel Ramírez, Rosa N Aleixandre, Rafael de Llorens

Clin Chim Acta· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.
Montserrat Ferrer-Batallé, Esther Llop, Manel Ramírez, Rosa Núria Aleixandre, Marc Saez, Rafael de Llorens

Int J Mol Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of prostate-specific antigen by two-dimensional gel electrophoresis and capillary electrophoresis.
Sílvia Barrabés, Noemi Farina-Gomez, Esther Llop, Angel Puerta, Jose Carlos Diez-Masa, Rafael de Llorens

Electrophoresis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer.
Bernardo Queralt, Elisabet Cuyàs, Joaquim Bosch-Barrera, Anna Massaguer, Rafael de Llorens

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology.
María José Ferri, Marc Saez, Joan Figueras, Esther Fort, Miriam Sabat, Rafael de Llorens

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Clara Panosa, Humphrey Fonge, Montserrat Ferrer-Batallé, Javier A Menéndez, Anna Massaguer, Rafael De Llorens

Nucl Med Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 3f Enable sutureless bioprosthesis: Early results, safeguards, and pitfalls.
Eduard Permanyer, Arnaldo-Javier Estigarribia, Alejandro Ysasi, Enrique Herrero, Omar Semper, Rafael Llorens

J Thorac Cardiovasc Surg· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.
Elisabet Cuyàs, Salvador Fernández-Arroyo, Bruna Corominas-Faja, Esther Rodríguez-Gallego, Joaquim Bosch-Barrera, Rafael De Llorens

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin.
Meritxell Balmaña, Ariadna Sarrats, Esther Llop, Sílvia Barrabés, Radka Saldova, Rafael de Llorens

Clin Chim Acta· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an epidermal growth factor derivative with EGFR blocking activity.
Clara Panosa, Francesc Tebar, Montserrat Ferrer-Batallé, Humphrey Fonge, Masaharu Seno, Rafael De Llorens

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
St. Jude Medical Trifecta™ aortic valve perioperative performance in 200 patients.
Eduard Permanyer, Arnaldo-Javier Estigarribia, Alejandro Ysasi, Enrique Herrero, Omar Semper, Rafael Llorens

Interact Cardiovasc Thorac Surg· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Marta Pérez-Garay, Beatriz Arteta, Esther Llop, Lara Cobler, Lluís Pagès, Rafael de Llorens

Int J Biochem Cell Biol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cells.
Sreeja C Sekhar, Tomonari Kasai, Ayano Satoh, Tsukasa Shigehiro, Akifumi Mizutani, Rafael de Llorens

J Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of new half sandwich ruthenium arene complexes with aminophosphines as potential chemotherapeutics.
Cristina Aliende, Mercedes Pérez-Manrique, Félix A Jalón, Blanca R Manzano, Ana M Rodríguez, Rafael de Llorens

J Inorg Biochem· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
Dolors Carrión-Salip, Clara Panosa, Javier A Menendez, Teresa Puig, Glòria Oliveras, Rafael De Llorens

Int J Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin subtype-2 receptor-targeted metal-based anticancer complexes.
Flavia Barragán, Dolors Carrion-Salip, Irene Gómez-Pinto, Alejandro González-Cantó, Peter J Sadler, Rafael de Llorens

Bioconjug Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis